Indiana Blood Center Selects Wyndgate's SafeTrace(R) Donor Management System DENVER, Nov. 8 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R), a division of Global Med Technologies(R), Inc., (OTC:GLOB) (BULLETIN BOARD: GLOB) continues to distinguish itself as a trusted partner to large donor center clients by announcing today that it has partnered with Indiana Blood Center (IBC) for its SafeTrace(R) donor management system. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) IBC is one of the nations largest independent blood banking institutes, collecting approximately 150,000 donations per year. Through these donations, IBC provides blood products to 48 hospitals throughout the state of Indiana supporting more than two million (2,000,000) Indiana residents. Wyndgate's SafeTrace system will assist IBC in accurately and efficiently managing the mass of information necessary to successfully run a large donor center, including donor scheduling, blood product manufacturing and infectious disease testing as well as blood product inventory, shipping and billing. In addition, SafeTrace will enable IBC to continue meeting the highest standards in the industry -- such as the ISBT 128 blood component labeling standard required to be implemented in 2008. Byron B. Buhner, President of Indiana Blood Center, says, "We are dependent on sophisticated information technology systems for enhancing our ability to work efficiently and to assure continued growth. We are pleased that Wyndgate's system will meet our needs now and in the future." Thomas F. Marcinek, President of Wyndgate Technologies, commented, "Indiana Blood Center is vital in supporting hospitals and communities across the state. IBC recognizes this important role and its need for a robust system that can fulfill its current management needs as well as help it continue to rise to ever higher standards." Mr. Marcinek continued, "IBC did not take its decision regarding a new blood management system lightly. IBC examined the entire market and took a considerable amount of time to seriously investigate its leading choices. In light of this thoroughness, Wyndgate is particularly proud to have been selected by IBC, which demonstrated the blood center's confidence in SafeTrace being able to meet IBC's needs. Wyndgate expanded its customer base with clients of varying sizes this year, and it is extremely gratifying to see our products continue to meet the diverse needs of the blood industry." About Indiana Blood Center: Indiana Blood Center (IBC) is a non-profit community service organization licensed by the FDA and the Indiana State Department of Health, and accredited by AABB. Founded in 1952, IBC takes seriously its mission to "provide a continuous, safe and adequate supply of blood products and testing services, first to the people in our own communities, then wherever our blood products and testing services are needed." IBC relies on the generosity of its donors to supply more than 550 units of blood each day to 48 Indiana hospitals. About Global Med Technologies, Inc. Global Med Technologies, Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the SafeTrace Tx(R)* advanced transfusion management system and the SafeTrace(R) donor management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. * Patent Pending http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies, Inc. CONTACT: Michael I. Ruxin, M.D., of Global Med Technologies, Inc., +1-303-238-2000 Web site: http://www.peoplemed.com/ Web site: http://www.wyndgate.com/ Web site: http://www.globalmedtech.com/

Copyright